Commentary on "Awake craniotomy with dexmedetomidine during resection of brain tumours located in eloquent regions"

Anaesthesiol Intensive Ther. 2023;55(2):131-132. doi: 10.5114/ait.2023.129310.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Brain Neoplasms* / surgery
  • Craniotomy*
  • Dexmedetomidine* / administration & dosage
  • Humans
  • Wakefulness

Substances

  • Dexmedetomidine